Abiopharma

Luda Technology Group Limited has signed a sales blanket agreement worth about RMB1.6 billion to supply pipeline fittings for the Yulong Island Refining and Chemical Integration Project (Phase one).

Bit Origin Outlined Strategic Priorities and Proposed Corporate Rebranding for Its Next Phase of Growth

GigaMedia Announces Second-Quarter 2026 Financial Results

Greenland Mines Departs for Skaergaard – Expanded 2026 Program Targeting Next Phase of Development

Securities Fraud Investigation Into Pentair plc (PNR) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

General Announcement: UPDATE ON LITIGATION

Williamson Douglas J 🟢 acquired 40.8K shares (1 derivative) of Vistagen Therapeutics, Inc. (VTGN) at $0.24 Transaction Date: Jul 29, 2026 | Filing ID: 000006

(75% Positive) IONQ, INC. (IONQ) Announces Business Combination

IonQ Completes Acquisition of SkyWater Technology

(99% Neutral) COLUMBUS ACQUISITION CORP/CAYMAN ISLANDS (COLAU) Announces Business Combination

(70% Positive) VISTAGEN THERAPEUTICS, INC. (VTGN) Provides Update on experience for neuroscience drug development

Steakholder Foods Ltd. Announces Up To $10.5 Million Private Placement

(99% Neutral) CITIZENS COMMUNITY BANCORP INC. (CZWI) Announces Regulatory Update